Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Robinetin
Cat. No.:
0225LY-1309
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Robinetin is a pentahydroxyflavone that exhibits strong antiradical and antioxidant properties, effectively preventing HbA glycosylation and lipid peroxidation in EYPC membranes.
Synonym:
3,3',4',5',7-Pentahydroxyflavone; 490-31-3; Robinetin; Norkanugin; 3,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one; 5-Hydroxyfisetin; 5-Deoxymyricetin; 4H-1-Benzopyran-4-one, 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-; 3,3',4',5',7-Pentahydroxyflavone; 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; 3,7,3',4',5'-pentahydroxyflavone; 3,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-4-benzopyrone; 3,7,3',4',5'-Pentahydroxuflavone
CAS No.:
490-31-3
Compound CID:
5281692
Formula:
C15H10O7
Formula Weight:
302.24
Specification
Relative Density:
1.3616 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Robinetin can be used in enzyme inhibition studies to explore its role as a natural flavonoid in regulating oxidative enzymes.
Library Information
Target:
HIV protease; Bacterial protein
Receptor:
HIV protease; Bacterial protein
Pathways:
Proteases/Proteasome; Microbiology/Virology
Plate Number:
AOCL-17
Plate Location:
g6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
100 mg/mL; 330.86 mM





